Milestones :: Perspectives :: Research
Russia: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
Russia: Sputnik V – “the first registered COVID-19 vaccine”
RDIF is inviting international scientists and scientific institutions to cooperate on research of real-world data/real-world evidence (RWD/RWE) on safety and efficacy of Sputnik V, Sputnik Light and other vaccines against coronavirus
Moscow, October 7, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) is inviting independent international researchers and scientific institutions to cooperate on real-world studies of safety and efficacy of coronavirus vaccines, including Sputnik V, Sputnik Light and others.
Key study topics:
Real-world studies on safety and efficacy of Sputnik V and Sputnik Light;
Efficacy factor analysis;
Comparative analysis of real-world data on safety and efficacy of Sputnik V, Sputnik Light and other vaccines;
Analysis of the real-world data on safety and efficacy of Sputnik Light as a booster.
Applicants conducting or planning to start scientific research in the abovementioned areas are kindly invited to contact RDIF and describe areas of interest and specific cooperation proposals via email@example.com …
The single-component Sputnik Light vaccine authorized in UAE
Press release, 06.10.2021